Trilogy International Partners Inc (TSE:TRL) had its price target lowered by Scotiabank from C$13.00 to C$12.50 in a research note published on Wednesday. The brokerage currently has an outperform rating on the specialty pharmaceutical company’s stock.

Separately, TD Securities restated a hold rating and issued a C$11.50 price objective on shares of Trilogy International Partners in a report on Friday, April 28th.

Shares of Trilogy International Partners (TRL) opened at 8.19 on Wednesday. The stock’s market capitalization is $361.81 million. The company’s 50-day moving average is $8.56 and its 200 day moving average is $9.42. Trilogy International Partners has a 12 month low of $8.07 and a 12 month high of $10.48.

COPYRIGHT VIOLATION NOTICE: This report was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.dailypolitical.com/2017/08/05/scotiabank-trims-trilogy-international-partners-inc-tsetrl-target-price-to-c12-50.html.

About Trilogy International Partners

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with MarketBeat.com's FREE daily email newsletter.